Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CARDINAL HEALTH INC | CEO, Pharmaceutical Segment | Common Shares | 106K | $11.3M | $107.08 | Aug 15, 2022 | Direct |
HERSHEY CO | Director | Common Stock | 4.35K | $860K | $197.54 | Oct 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
HSY | HERSHEY CO | Oct 1, 2024 | 1 | $0 | 4 | Oct 2, 2024 | Director |
HSY | HERSHEY CO | Jul 1, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
HSY | HERSHEY CO | Apr 1, 2024 | 1 | $0 | 4 | Apr 3, 2024 | Director |
HSY | HERSHEY CO | Jan 1, 2024 | 1 | $0 | 4/A | Jan 26, 2024 | Director |
HSY | HERSHEY CO | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Director |
HSY | HERSHEY CO | Oct 1, 2023 | 1 | $0 | 4 | Oct 3, 2023 | Director |
HSY | HERSHEY CO | Jul 1, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Director |
HSY | HERSHEY CO | Apr 1, 2023 | 1 | $0 | 4 | Apr 4, 2023 | Director |
HSY | HERSHEY CO | Jan 1, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
HSY | HERSHEY CO | Oct 1, 2022 | 1 | $0 | 4 | Oct 3, 2022 | Director |
CAH | CARDINAL HEALTH INC | Aug 15, 2022 | 2 | -$2.08M | 4 | Aug 17, 2022 | CEO, Pharmaceutical Segment |
CAH | CARDINAL HEALTH INC | Aug 9, 2022 | 1 | $0 | 4 | Aug 11, 2022 | CEO, Pharmaceutical Segment |
HSY | HERSHEY CO | Jul 1, 2022 | 1 | $0 | 4 | Jul 5, 2022 | Director |
HSY | HERSHEY CO | Apr 1, 2022 | 1 | $0 | 4 | Apr 4, 2022 | Director |
HSY | HERSHEY CO | Jan 1, 2022 | 1 | $0 | 4 | Jan 3, 2022 | Director |
CAH | CARDINAL HEALTH INC | Nov 15, 2021 | 1 | -$226K | 4 | Nov 16, 2021 | CEO, Pharmaceutical Segment |
HSY | HERSHEY CO | Oct 1, 2021 | 1 | $0 | 4 | Oct 1, 2021 | Director |
CAH | CARDINAL HEALTH INC | Aug 15, 2021 | 2 | -$1.03M | 4 | Aug 17, 2021 | CEO, Pharmaceutical Segment |
CAH | CARDINAL HEALTH INC | Aug 3, 2021 | 1 | $0 | 4 | Aug 5, 2021 | CEO, Pharmaceutical Segment |
HSY | HERSHEY CO | Jul 1, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |